- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06462131
Culturally Adapted Group Cognitive Behavior Therapy (CaGCBT-SUDs) for Substance Use Disorders and Their Caregivers (CaGCBT-SUDs)
Effectiveness of Culturally Adapted Group Cognitive Behavior Therapy on Adults With Substance Use Disorders and Their Caregivers: A Randomized Control Trial From Pakistan
Study Overview
Status
Intervention / Treatment
Detailed Description
Substance use has life-long impacts not only on an individual life but on their families as well. Research indicates a surge in substance use disorders in the last two decades across the globe and Pakistan has no exception. UNDP's report on drug/substance use indicates alarming prevalence rates. Furthermore, the research identifies that substance use disorder has unfavorable effects individual's quality of life and well-being. SUD places significant strain on family members and involving family caregivers in the treatment plan for opioid addiction has led to negative outcomes for the caregiver, such as depression and caregiver burden. Several researchers found that families of individuals with SUDs experience economic burden, social isolation, psychological strain, shame, embarrassment, guilt, self-blame, marital problems, and threats to their physical health. Therefore, it is important to treat SUDs as well as the burden of caregiving.
Many treatment modules have been developed to treat SUDs. Among them, group therapy was found more effective than individual therapy. CSAT lists five effective group therapy models: (1) psychoeducational groups, (2) skill development groups, (3) cognitive-behavior or problem-solving groups, (4) support groups, and (5) interpersonal groups. Furthermore, a lot of treatment modules for SUDs have been in practice. Among them, group therapy was found to be most effective in treating psychiatric or psychological issues. Furthermore, group CBT was found as effective as individual CBT. Cognitive therapy attempts to reduce excessive emotional reactions and self-defeating behaviors that are prevalent in adults with substance use disorders by modifying faulty and erroneous thinking and maladaptive beliefs that underlie these reactions. CBT for SUDs developed by Liese & Beck is based on a collaborative (trust-building), active, based on open-ended questions to a large degree, highly structured, and focused approach that gives more advantages to this therapy as compared to other therapy modalities.
Cognitive Behavior Therapy helps adults with substance use disorders to overcome their problems leading to emotional distress and helps them to visualize in a broader perspective their dependence on drugs of their choice for pleasure / or relief of discomfort. Moreover, CBT also helps to reduce the intensity and frequency of the urges by addressing their underlying beliefs and teaching them relevant techniques to not only control and manage their urges but also help them remain abstinent from the use of drugs, manage their daily life problems and thus have a more enjoyable and fulfilling life.
The following research project is based on the Cognitive-behavioral Model of problem-solving because it is a goal-directed approach that focuses on the current position of patients and mainly targets the patient's maladaptive cognitive, behavioral, and emotional patterns. Additionally, CBT techniques and planning of treatment particularly target the patient's core beliefs. If the patient's illogical beliefs change into logical and rational beliefs, the patient starts to believe that he can cope with his problems and that his problems are manageable. Core beliefs, underlying assumptions, and even the content of automatic thoughts vary across cultures. Cultural and sub-cultural backgrounds also influence beliefs about well-being, causes of illness and its cure, help-seeking behaviors, healing systems, and even the healers. The group therapy for SUDs has been developed in the West, therefore, by culturally adapting the intervention, benefits can be broadened in areas other than the West. In Pakistan, CBT has been culturally adapted for internalizing disorders such as depression and anxiety. There is a dearth of research that focuses on cultural adaptation of Group CBT especially for individuals diagnosed with SUDs.
Keeping in the backdrop to the premise, our focal point of the study would be to culturally adapt group CBT for Substance Use Disorders by Liese and Beck and to check its effectiveness on adults with substance use disorders. Further to check the effectiveness of culturally adapted CBT to treat depression and anxiety symptoms in the caregivers of SUDs in Pakistan.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Balochistan
-
Quetta, Balochistan, Pakistan, 87300
- BMC Psychiatry
-
-
Federal Capital Area
-
Islamabad, Federal Capital Area, Pakistan, 45000
- ANF rehabilitation Centre
-
-
KPK
-
Peshawar, KPK, Pakistan, 25000
- Dr. Mian Iftekhar Psychiatry Hospital
-
-
Punjab
-
Lahore, Punjab, Pakistan, 05450
- Life Care International Hospital
-
-
Sindh
-
Karachi, Sindh, Pakistan, 05444
- Parwarish Rehabilitation centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosed individuals with substance use disorder within the age bracket of 18-64 years.
- In-patient of rehabilitation center and detoxified for 2 months
- Able to give written informed consent
- Able to read and speak Urdu
Exclusion Criteria:
- Presence of a diagnosed physical or intellectual disability as it can prevent individuals from engaging with the intervention. This will be assessed by the research team at screening stage. Any disabilities will be identified by a relevant clinician (e.g., Psychiatrist).
- Temporary resident unlikely to be available for follow-up
- Being detoxified less than 2 months
- Individuals with substance use disorder having follow up with rehabilitation center
- Having Comorbidity with psychological disturbances like depression, anxiety etc.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CaGCBT with TAU
In this group, CaGCBT-SUD along with TAU will be provided.
|
In first session, introduction of the therapist/facilitator and group members will be made.
Group rules will be discussed with members.
Group members' introduction primarily focuses on participant/clients' expectations, addictive behaviors and its status, and goals.
Moreover, it also emphasize on identification of any other significant issue that is contributing in burden of disease.
|
|
Active Comparator: CBTAG with TAU and with caregivers
In this group, CaGCBT-SUD along with TAU will be provided.
Moreover caregivers will be provided psychoeducation
|
In first session, introduction of the therapist/facilitator and group members will be made.
Group rules will be discussed with members.
Group members' introduction primarily focuses on participant/clients' expectations, addictive behaviors and its status, and goals.
Moreover, it also emphasize on identification of any other significant issue that is contributing in burden of disease.
|
|
No Intervention: No intervention only TAU
Treatment as usual
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Addiction Severity Index-Lite Version
Time Frame: Upto 8-12 weeks
|
The ASI covers the following areas: medical, employment/support, drug and alcohol use, legal, family/social, and psychiatric.
The ASI obtains lifetime information about problem behaviors, as well as problems within the previous 30 days.
The ASI-Lite contains 22 fewer questions than the ASI, and omits items relating to severity ratings, and a family history grid.
The higher a subject scores on the ASI, the greater the indication of a need for treatment.
|
Upto 8-12 weeks
|
|
Revised Mental Health Inventory- 5
Time Frame: Upto 8-12 weeks
|
The MHI-5 was developed for its use with the general population, and it includes items on psychological well-being.
The total score ranges from 0 to 15, with higher scores indicating better mental health.
|
Upto 8-12 weeks
|
|
The Readiness to Change Questionnaire
Time Frame: Upto 8-12 weeks
|
designed to assess stages of change in substance abusers, in terms of the Prochaska and DiClemente stages of change model.
The score ranges for each scale is -10 through 0 to +10.
Score towards positive end indicates patients' readiness to change.
|
Upto 8-12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Relapse Risk Scale
Time Frame: Upto 8-12 weeks
|
It is a 44-item self-report multidimensional instrument, which proposes to measure relapse risk among substance dependents.
Lower scores indicate low risk of relapse while high scores are indicative of higher risk of relapse.
|
Upto 8-12 weeks
|
|
Coping Strategies Scale
Time Frame: Upto 8-12 weeks
|
The CSS is comprised of 48 items intended to tap potential coping strategies that might be used by patients in to remain abstinent.
Respondents rate the frequency (from 1 = never to 4 = frequently) of using specific strategies in the past 3 months.
Total coping on the CSS was calculated by taking the mean across all 48 items.
|
Upto 8-12 weeks
|
|
WHO Quality of Life- Brief version
Time Frame: Upto 8-12 weeks
|
It consists of 24 items to assess perception of quality of life in four domains, including physical health, psychological, social relationships and environment, and two items on overall QOL and general health.
A higher score indicated a better quality of life.
|
Upto 8-12 weeks
|
|
Subjective Well-being Scale
Time Frame: Upto 8-12 weeks
|
Subjective well-being will be measured by using following three scales: 1. PANAS (Use 5 point Likert scale to identify the positive or negative emotion experienced across week); 2. SWL(measures individuals' global cognitive judgments of their life as a whole in relation to a self-imposed ideal using five items (e.g., "In most ways my life is close to my ideal") and a seven point Likert scale (1 = strongly disagree, 7 = strongly agree); 3. HLS (assess a person's global sense of harmony in life and consists of five statements (e.g., "My lifestyle allows me to be in harmony") for which respondents are asked to indicate degree of agreement on a seven-point Likert scale (1 = strongly disagree, 7 = strongly agree).
|
Upto 8-12 weeks
|
|
Family Burden Interview Schedule
Time Frame: Upto 8-12 weeks
|
It has 24 items each rated on a three-point scale: 0, no burden; 1. moderate burden; and 2, severe burden.
|
Upto 8-12 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Anila Sadaf, PhD, NUML
- Study Director: Rizwana Amin, Bahria University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Ref No.20-16628/NRPU/R&D/HEC/
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Treatment
-
University of PadovaUniversity of Turin, ItalyNot yet recruiting
-
Psychiatric Centre RigshospitaletAstraZenecaTerminatedMedical Treatment | Antipsychotic Treatment | Quality AssuranceDenmark
-
Vilniaus Implantologijos Centro (VIC) KlinikaInstitut Straumann AGActive, not recruitingSingle Implant; Immediate Implant Treatment; Early Implant TreatmentLithuania
-
Sunnybrook Health Sciences CentreRecruitingTreatment-Resistant Depression | Treatment-resistant Depression (TRD)Canada
-
Chinese PLA General HospitalNot yet recruitingTreatment for Advanced Colorectal Cancer | Treatment for Advanced Pancreatic Cancer
-
Dr. Stavroula RakitziActive, not recruitingTreatment Resistant Schizophrenia | Treatment Resistant Bipolar DisorderGreece
-
NeuroRx, Inc.neurocare group AG; Zeta Surgical, Inc.; HOPE Therapeutics, Inc.Not yet recruitingTreatment Resistant Depression | Treatment Resistant Depression (TRD)United States
-
Ajman UniversityCompletedTreatmentUnited Arab Emirates
-
Nanjing University School of MedicineCompleted
-
Entheon Biomedical Corp.TerminatedTreatment-resistant DepressionUnited States
Clinical Trials on Cultural Adapted Group cognitive Behaviroal therapy (CaGCBT)
-
Nottingham Trent UniversitySheffield Hallam University; University of Manchester; Teesside UniversityRecruitingPostnatal DepressionUnited Kingdom
-
Vanderbilt University Medical CenterCompletedDepression | Suicidal Ideation | Autism Spectrum Disorder | Self EsteemUnited States
-
Nottingham Trent UniversitySheffield Hallam University; University of Manchester; Teesside University; University...Not yet recruiting
-
Claremont McKenna CollegeUniversity of California, Los AngelesCompleted
-
Goethe UniversityKatholische Universität Eichstätt Ingolstadt; Freie Universität BerlinCompleted
-
RANDNational Institute of Mental Health (NIMH)CompletedPost-Traumatic Stress DisorderUnited States
-
Bahria UniversityCompletedInternet Gaming DisorderPakistan
-
Istanbul Sehir UniversityCompletedPsychological Distress | Psychological TraumaTurkey
-
University of ManchesterNot yet recruitingPsychosis | Schizophrenia Spectrum DisordersUnited Kingdom
-
Children's National Research InstitutePatient-Centered Outcomes Research Institute; George Washington UniversityActive, not recruitingPerinatal Depression | Prenatal Stress | Perinatal AnxietyUnited States